Viewing Study NCT02722135


Ignite Creation Date: 2025-12-24 @ 10:35 PM
Ignite Modification Date: 2025-12-31 @ 3:11 PM
Study NCT ID: NCT02722135
Status: WITHDRAWN
Last Update Posted: 2017-01-27
First Post: 2016-03-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Find a Safe Dose of Volasertib Given in Addition to Standard Salvage Chemotherapy in Children (Age 3 Months to Less Than 18 Years) With Acute Myeloid Leukaemia, in Whom Front-line Chemotherapy Failed
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module